Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY1 | P47900 | 4/20 | 0.66 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.66 |
| ▸ | P2RY2 | P41231 | 3/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.66 |
| ▸ | SRC | P12931 | 2/20 | 0.66 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.66 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.66 |
| ▸ | TRPM2 | O94759 | 1/20 | 0.66 |
| ▸ | LDHA | P00338 | 1/20 | 0.66 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.66 |
| ▸ | FBP1 | P09467 | 1/20 | 0.66 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.66 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.66 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.66 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.66 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.66 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.66 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.66 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.66 |
| ▸ | P2RY11 | Q96G91 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4356493 | 1.00 | P2RY1 (0.66) | P2RY1ADORA1P2RY2SMN1; SMN2SRC | |
| SCHEMBL3699269 | 0.90 | P2RY1 (0.68) | P2RY1ADORA1P2RY2SMN1; SMN2SRC | |
| SCHEMBL1723484 | 0.89 | P2RY1 (0.70) | P2RY1ADORA1P2RY2SMN1; SMN2SRC | |
| SCHEMBL1000175 | 0.88 | P2RY1 (0.68) | P2RY1ADORA1P2RY2SMN1; SMN2SRC | |
| SCHEMBL8708990 | 0.88 | ADORA1 (0.71) | P2RY1ADORA1P2RY2SMN1; SMN2SRC | |
| SCHEMBL28978257 | 0.87 | P2RY1 (0.65) | P2RY1ADORA1P2RY2SMN1; SMN2SRC | |
| SCHEMBL6569310 | 0.87 | ADORA1 (0.73) | P2RY1ADORA1P2RY2SMN1; SMN2SRC | |
| SCHEMBL10586180 | 0.86 | P2RY1 (0.68) | P2RY1ADORA1P2RY2SMN1; SMN2SRC | |
| SCHEMBL11519682 | 0.86 | P2RY1 (0.68) | P2RY1ADORA1P2RY2SMN1; SMN2SRC | |
| SCHEMBL30637132 | 0.86 | P2RY1 (0.68) | P2RY1ADORA1P2RY2SMN1; SMN2SRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 251 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023222829-A1 | DESIGNED BIOSENSORS FOR ENHANCED T CELL THERAPY | CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS (CH) | 2023-11-23 | — | — | WO | claimed |
| EP-2204154-B1 | Association of monosaccharides and adenosine and its cosmetic use | ORÉAL L (FR) | 2016-10-12 | — | — | EP | claimed |
| EP-2204154-A1 | Association of monosaccharides and adenosine and its cosmetic use | L'OREAL (FR) | 2010-07-07 | — | — | EP | claimed |
| WO-2010065959-A1 | METHOD OF PREPARING ADENOSINE-RESISTANT ANTI-TUMOR T LYMPHOCYTES FOR ADOPTIVE IMMUNOTHERAPY | NORTHEASTERN UNIVERSITY (US) | 2010-06-10 | — | — | WO | claimed |
| WO-2008075201-A2 | EPIGALLOCATECHIN-3-GALLATE COMPOSITIONS FOR CANCER THERAPY AND CHEMOPROTECTION | UNIVERSIDAD DE MURCIA (ES) | 2008-06-26 | — | — | WO | claimed |
| WO-2007042679-A2 | COSMETIC COMPOSITION CONTAINING A NON-PHOSPHATE COMPOUND BASED ON ADENOSINE AND A TIGHTENING POLYMER | L'OREAL (FR) | 2007-04-19 | — | — | WO | claimed |
| EP-1638579-A2 | COMPOSITIONS AND METHODS FOR USE OF A PROTEASE INHIBITOR AND ADENOSINE FOR PREVENTING ORGAN ISCHEMIA AND REPERFUSION INJURY | EMORY UNIVERSITY (US) | 2006-03-29 | — | — | EP | claimed |
| WO-2005003150-A2 | COMPOSITIONS AND METHODS FOR USE OF A PROTEASE INHIBITOR AND ADENOSINE FOR PREVENTING ORGAN ISCHEMIA AND REPERFUSION INJURY | EMORY UNIVERSITY (US) | 2005-01-13 | — | — | WO | claimed |
| WO-2004056181-A1 | ORGAN PRECONDITIONING, ARREST, PROTECTION, PRESERVATION AND RECOVERY (2) | GLOBAL CARDIAC SOLUTIONS PTY LTD (AU) | 2004-07-08 | — | — | WO | claimed |
| WO-2004056180-A1 | ORGAN PRECONDITIONING, ARREST, PROTECTION, PRESERVATION AND RECOVERY (1) | GLOBAL CARDIAC SOLUTIONS PTY LTD (AU) | 2004-07-08 | — | — | WO | claimed |
| EP-1272897-A2 | ADENOSINE A2A RECEPTOR ANTAGONISTS FOR TREATING AND PREVENTING HEPATIC FIBROSIS, CIRRHOSIS AND FATTY LIVER | NEW YORK UNIVERSITY (US) | 2003-01-08 | — | — | EP | claimed |
| WO-2001058241-A9 | ADENOSINE A2A RECEPTOR ANTAGONISTS FOR TREATING AND PREVENTING HEPATIC FIBROSIS, CIRRHOSIS AND FATTY LIVER | UNIV NEW YORK (US) | 2002-10-17 | — | — | WO | claimed |
| EP-1168912-A4 | ORGAN ARREST, PROTECTION AND PRESERVATION | UNIV JAMES COOK (AU) | 2002-07-31 | — | — | EP | claimed |
| WO-2002029408-A2 | METHODS FOR DIAGNOSING AND TREATING HUNTINGTON'S DISEASE | UNIVERSITA' DEGLI STUDI DI MILANO (IT) | 2002-04-11 | — | — | WO | claimed |
| EP-1168912-A1 | ORGAN ARREST, PROTECTION AND PRESERVATION | James Cook University (AU) | 2002-01-09 | — | — | EP | claimed |
| WO-2001058241-A2 | ADENOSINE A2A RECEPTOR ANTAGONISTS FOR TREATING AND PREVENTING HEPATIC FIBROSIS, CIRRHOSIS AND FATTY LIVER | NEW YORK UNIVERSITY (US) | 2001-08-16 | — | — | WO | claimed |
| WO-2000056145-A1 | ORGAN ARREST, PROTECTION AND PRESERVATION | JAMES COOK UNIVERSITY (AU) | 2000-09-28 | — | — | WO | claimed |
| EP-0689405-A4 | METHODS FOR PROTECTING TISSUES AND ORGANS FROM ISCHEMIC DAMAGE | GENSIA INC (US) | 1996-09-11 | — | — | EP | claimed |
| EP-0689405-A1 | METHODS FOR PROTECTING TISSUES AND ORGANS FROM ISCHEMIC DAMAGE | GENSIA, INC. (US) | 1996-01-03 | — | — | EP | claimed |
| WO-1994021195-A1 | METHODS FOR PROTECTING TISSUES AND ORGANS FROM ISCHEMIC DAMAGE | GENSIA, INC. (US) | 1994-09-29 | — | — | WO | claimed |